SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001019687-15-000296
Filing Date
2015-01-22
Accepted
2015-01-22 16:00:10
Documents
4
Period of Report
2015-01-15
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ON FORM 8-K vglife_8k.htm 8-K 23174
2 WARRANT vglife_8k-ex401.htm EX-4.1 36346
3 CONVERTIBLE PROMISSORY NOTE AND WARRANT PURCHASE AGREEMENT vglife_8k-ex1001.htm EX-10.1 132824
4 CONVERTIBLE PROMISSORY NOTE vglife_8k-ex1002.htm EX-10.2 48109
  Complete submission text file 0001019687-15-000296.txt   242083
Mailing Address 121 GRAY AVENUE, SUITE 200 SANTA BARBARA CA 93101
Business Address 121 GRAY AVENUE, SUITE 200 SANTA BARBARA CA 93101 805-879-9000
VG Life Sciences Inc. (Filer) CIK: 0001091326 (see all company filings)

IRS No.: 330814123 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-26875 | Film No.: 15541841
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1